Methylene Blue for Postcardiopulmonary Bypass Vasoplegic Syndrome: A Cohort Study
Open Access
- 1 April 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Cardiac Anaesthesia
- Vol. 20 (2) , 178-181
Abstract
Background: Methylene blue (MB) has been used to treat refractory hypotension in a variety of settings. Aims: We sought to determine whether MB improved blood pressure in postcardiopulmonary bypass (CPB) vasoplegic syndrome (VS) in a complex cardiac surgery population. Furthermore, to determine variables that predicted response to MB. Setting and Design: This was conducted in a tertiary care medical center; this study was a retrospective cohort study. Materials and Methods: Adult cardiac surgery patients who received MB for post-CPB VS over a 2-year period were studied. Mean arterial blood pressure (MAP) and vasopressor doses were compared before and after MB, and logistic regression was used to model which variables predicted response. Results: Eighty-eight patients received MB for post-CPB VS during the study period. MB administration was associated with an 8 mmHg increase in MAP (P = 0.004), and peak response occurred at 2 h. Variables that were associated with a positive drug response were deep hypothermic circulatory arrest during surgery and higher MAP at the time of drug administration (P = 0.006 and 0.02). A positive response had no correlation with in-hospital mortality (P = 0.09). Conclusions: MB modestly increases MAP in cardiac surgery patients with VS. Higher MAP at the time of drug administration and surgery with deep hypothermic circulatory arrest predict a greater drug response.Keywords
This publication has 12 references indexed in Scilit:
- Cardiac Vasoplegia Syndrome: Pathophysiology, Risk Factors and TreatmentThe American Journal of the Medical Sciences, 2015
- Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revisedBrazilian Journal of Cardiovascular Surgery, 2014
- Methylene blue as a vasopressor: a meta-analysis of randomised trialsCritical Care and Resuscitation, 2013
- Survival After Shock Requiring High-Dose Vasopressor TherapyChest, 2013
- Methylene Blue: Revisited2010
- Vasoplegia During Cardiac Surgery: Current Concepts and ManagementSeminars in Thoracic and Cardiovascular Surgery, 2010
- Early On–Cardiopulmonary Bypass Hypotension and Other Factors Associated With Vasoplegic SyndromeCirculation, 2009
- Vasoplegic syndrome—the role of methylene blueEuropean Journal of Cardio-Thoracic Surgery, 2005
- Preoperative Methylene Blue Administration in Patients at High Risk for Vasoplegic Syndrome During Cardiac SurgeryThe Annals of Thoracic Surgery, 2005
- Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgeryThe Annals of Thoracic Surgery, 2004